Price to Operating Profit (P/OP)
since 2005
Calculation
Regeneron Pharmaceuticals Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income (loss) from operations1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | 25.39 | = | 936.33 | ÷ | 36.87 | 36.87 | = | 4,047,100 | ÷ | 109,761,896 | |
| Feb 6, 2023 | 18.01 | = | 780.86 | ÷ | 43.35 | 43.35 | = | 4,738,900 | ÷ | 109,325,532 | |
| Feb 7, 2022 | 7.55 | = | 622.36 | ÷ | 82.43 | 82.43 | = | 8,946,800 | ÷ | 108,539,282 | |
| Feb 8, 2021 | 14.82 | = | 494.90 | ÷ | 33.39 | 33.39 | = | 3,576,600 | ÷ | 107,131,899 | |
| Feb 7, 2020 | 19.01 | = | 381.87 | ÷ | 20.09 | 20.09 | = | 2,209,800 | ÷ | 110,019,809 | |
| Feb 7, 2019 | 17.53 | = | 406.46 | ÷ | 23.19 | 23.19 | = | 2,534,400 | ÷ | 109,277,189 | |
| Feb 8, 2018 | 16.71 | = | 322.62 | ÷ | 19.31 | 19.31 | = | 2,079,591 | ÷ | 107,696,798 | |
| Feb 9, 2017 | 28.70 | = | 360.00 | ÷ | 12.54 | 12.54 | = | 1,330,741 | ÷ | 106,080,755 | |
| Feb 11, 2016 | 30.74 | = | 367.24 | ÷ | 11.95 | 11.95 | = | 1,251,916 | ÷ | 104,788,145 | |
| Feb 12, 2015 | 49.17 | = | 401.74 | ÷ | 8.17 | 8.17 | = | 838,431 | ÷ | 102,616,962 | |
| Feb 13, 2014 | 42.99 | = | 326.98 | ÷ | 7.61 | 7.61 | = | 760,028 | ÷ | 99,928,368 | |
| Feb 15, 2013 | 35.11 | = | 164.93 | ÷ | 4.70 | 4.70 | = | 457,713 | ÷ | 97,450,601 | |
| Feb 21, 2012 | — | = | 99.26 | ÷ | -2.19 | -2.19 | = | -205,159 | ÷ | 93,888,977 | |
| Feb 17, 2011 | — | = | 37.67 | ÷ | -1.08 | -1.08 | = | -97,472 | ÷ | 89,959,044 | |
| Feb 18, 2010 | — | = | 26.66 | ÷ | -0.91 | -0.91 | = | -74,103 | ÷ | 81,653,378 | |
| Feb 26, 2009 | — | = | 15.40 | ÷ | -1.12 | -1.12 | = | -89,830 | ÷ | 79,976,762 | |
| Feb 27, 2008 | — | = | 18.90 | ÷ | -1.45 | -1.45 | = | -114,454 | ÷ | 78,984,745 | |
| Mar 12, 2007 | — | = | 19.04 | ÷ | -1.64 | -1.64 | = | -107,655 | ÷ | 65,630,744 | |
| Feb 28, 2006 | — | = | 16.37 | ÷ | -2.19 | -2.19 | = | -124,421 | ÷ | 56,858,721 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Regeneron Pharmaceuticals Inc. Annual Report.
Comparison to Competitors
Regeneron Pharmaceuticals Inc., P/OP, long-term trends, comparison to competitors
| Regeneron Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Moderna Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | 25.39 | 24.34 | 19.69 | 35.64 | 12.05 | — | 31.16 |
| Feb 6, 2023 | 18.01 | 14.78 | 13.40 | 20.97 | 14.21 | 5.71 | 25.30 |
| Feb 7, 2022 | 7.55 | 14.21 | 16.24 | 25.14 | 7.76 | 4.59 | 21.07 |
| Feb 8, 2021 | 14.82 | 16.32 | 14.96 | 36.91 | 19.38 | — | 22.81 |
| Feb 7, 2020 | 19.01 | 10.82 | 13.84 | 34.47 | 20.66 | — | 26.84 |
| Feb 7, 2019 | 17.53 | 18.35 | 11.46 | 23.18 | 10.15 | — | 27.33 |
| Feb 8, 2018 | 16.71 | 19.63 | 12.71 | 22.48 | 7.45 | — | 28.24 |
| Feb 9, 2017 | 28.70 | 10.49 | 12.64 | 21.37 | 5.23 | — | 25.13 |
| Feb 11, 2016 | 30.74 | 11.61 | 13.07 | 17.27 | 5.50 | — | 22.15 |
| Feb 12, 2015 | 49.17 | 28.64 | 19.13 | 17.94 | 10.19 | — | 20.63 |
| Feb 13, 2014 | 42.99 | 14.31 | 16.19 | 16.24 | 28.54 | — | 30.40 |
| Feb 15, 2013 | 35.11 | 10.44 | 12.22 | 13.40 | 16.28 | — | 17.92 |
| Feb 21, 2012 | — | — | 12.48 | 14.04 | 9.02 | — | 16.64 |
| Feb 17, 2011 | — | — | 8.79 | 15.14 | 7.82 | — | 17.09 |
| Feb 18, 2010 | — | — | 10.12 | 15.63 | 12.16 | — | 19.04 |
| Feb 26, 2009 | — | — | 9.70 | 8.85 | 15.24 | — | 12.33 |
| Feb 27, 2008 | — | — | 12.44 | 13.65 | 18.80 | — | 24.03 |
| Mar 12, 2007 | — | — | 19.54 | 14.52 | — | — | 79.09 |
| Feb 28, 2006 | — | — | 17.96 | 15.18 | 25.01 | — | 21.48 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).